Llwytho...
Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy
With 185 million people chronically infected globally, hepatitis C is a leading bloodborne infection. All-oral regimens of direct acting agents have superior efficacy compared to the historical interferon-based regimens and are significantly more tolerable. However, trials of both types of regimens...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Clin Transl Hepatol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
XIA & HE Publishing Inc.
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075004/ https://ncbi.nlm.nih.gov/pubmed/27777889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00017 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|